ArticleBMC medical informatics and decision making2026
Artificial intelligence-based approaches for monitoring medication adherence among cardiovascular disease patients: a scoping review.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular diseases (CVDs) are still a leading cause of death worldwide, and the impact of the disease in lower-income countries is dire. Patients must take medications on a regular basis for effective management of CVD; however, the level of efficacious self-management is far below what is required. Artificial Intelligence (AI) shows promise in evaluating different data sets, aiding in clinical decision processes, and facilitating active engagement in the self-management of medication. The purpose of this scoping review was to analyse the available literature on the approaches that have been employed in using AI to improve medication adherence in patients with CVD.
methodsThis research was done according to the PRISMA-ScR guidelines. A comprehensive literature search was conducted on June 19, 2025, across PubMed, Embase, CINAHL, Scopus, and Web of Science using pre-established eligibility standards. Screening was done using Rayyan across two stages. Data was extracted on the characteristics of the study, AI-based approaches and their methods, measures of adherence, and the outcomes reported.
resultsSixteen studies were included based on the inclusion criteria. The included studies varied in setting, sample size, and disease conditions. AI-based approaches comprised natural language processing, reinforcement learning, and machine learning algorithms such as neural networks, random forests, support vector machines, and decision tree models. Interventions were delivered through smartphone applications, clinical workflow systems, Internet of Things (IoT) enabled devices, and chatbots. Medication adherence was assessed using pharmacy refill data, electronic health records (EHR), validated surveys, device-based monitoring, administrative claims, and biochemical testing. Several AI-based approaches showed improvements in adherence; however, across studies, reports were inconsistent, and methodological variation limited comparability. Evidence from low- and middle-income countries remained limited.
conclusionAI-based approaches have been applied to monitor and support medication adherence among patients with CVD; however, the outcome measures are inconsistent due to limited population diversity and variable study quality, restricting the comparability across existing evidence. Standardized adherence metrics, rigorous methodologies, and broader evaluations in diverse settings are essential to strengthen future research and support real-world decisions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.